BioSpace News Archive

Medtronic Evaluates Insertable Cardiac Monitor in Identifying Patients at High Risk of Worsening Heart Failure

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced first enrollments in the ALLEVIATE-HF clinical trial which will evaluate the ability of its Reveal LINQ™ Insertable Cardiac Monitor (ICM) in identifying patients at high-risk of worsening heart failure

September 23, 2020
·
5 min read
Pharm Country

Wearable Technology Could Prevent COVID-19 Complications And Death For People Recovering At Home

New Study at Montefiore Aims to Identify Who Can be Cared for at Home and Who Would Benefit from Hospital Care

September 23, 2020
·
5 min read
Business

Allevion Therapeutics Closes Additional Funding and Announces New Board Member, Jack Wang, Ph.D.

Jack Wang, Ph.D., is the newest member to join to Allevion Therapeutics’ board of directors.

September 23, 2020
·
2 min read
FDI World Dental Federation and Smile Train: Children with clefts are at high risk for tooth decay, gum disease and other serious oral health concerns

Cleft lip and palate (clefts) are the most common birth difference of the face and mouth and impact the development of the mouth, gums, and palate.

September 23, 2020
·
3 min read
Business

InSysBio announces its collaboration with Genmab

InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces its collaboration with Genmab, an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer

September 23, 2020
·
2 min read
Ardigen has received funding to accelerate its AI-driven TCR discovery platform for novel cell therapies

Ardigen, a company applying Artificial Intelligence to Precision Medicine, has signed a grant agreement with the National Centre for Research and Development for the funding of a novel technology that will revolutionize the development of TCR-based therapies in immuno-oncology.

September 23, 2020
·
2 min read
Pharm Country

New Study Indicates that KUBTEC’s Mozart® 3D Specimen Imaging Decreases Re-Excision Rates for Breast Lumpectomies By More Than 50%

A new study in the Annals of Surgical Oncology demonstrates that Kubtec Medical Imaging’s Mozart® 3D specimen tomosynthesis technology reduces the need for re-excision following breast cancer surgery by more than 50% when compared with 2D-image guided radiographs.

September 23, 2020
·
3 min read
Pharm Country

The Bloc’s New Science Foundry Practice Merges Science With Behavorial Psychology To Transform Medical Communications

The leading independent health creative agency, The Bloc, announced today the launch of The Bloc Science Foundry, a groundbreaking new medical communications practice area that merges deep scientific expertise with applied behavioral psychology research.

September 23, 2020
·
3 min read
Biotech Beach

Neurelis Announces Program To Investigate The Safety And Pharmacokinetics Of VALTOCO® (Diazepam Nasal Spray) In Children Aged 2 To 5

Neurelis, Inc., announced today that it will be investigating the safety and pharmacokinetics of the company’s lead product, VALTOCO® (diazepam nasal spray), in children with epilepsy aged two to five.

September 23, 2020
·
6 min read
Pharm Country

Seelos Therapeutics Announces Sponsored Research Agreement with Duke University for Gene Therapy Studies of SLS-004 in Parkinson’s Disease

Seelos Therapeutics, Inc. (Nasdaq: SEEL), announced today the signing of a Sponsored Research Agreement (SRA) with Duke University to use the MPTP-induced Parkinson’s Disease (PD) mouse model to establish in vivo proof-of-concept study to demonstrate that administration of LV-dCas9-DNMT3A

September 23, 2020
·
4 min read